Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanomedicine from amphiphilized prodrugs: Concept and clinical translation
Jiajia Xiang, Xin Liu, Guiping Yuan, et al.
Advanced Drug Delivery Reviews (2021) Vol. 179, pp. 114027-114027
Closed Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Biomedical polymers: synthesis, properties, and applications
Wei‐Hai Chen, Qi‐Wen Chen, Qian Chen, et al.
Science China Chemistry (2022) Vol. 65, Iss. 6, pp. 1010-1075
Open Access | Times Cited: 130
Stimulus-responsive self-assembled prodrugs in cancer therapy
Xiao Dong, Rajeev Kungur Brahma, Chao Fang, et al.
Chemical Science (2022) Vol. 13, Iss. 15, pp. 4239-4269
Open Access | Times Cited: 84
Nano Delivery of Chemotherapeutic ICD Inducers for Tumor Immunotherapy
Jianfeng Guo, Yifang Zou, Leaf Huang
Small Methods (2023) Vol. 7, Iss. 5
Closed Access | Times Cited: 58
A Dendritic Polymer‐Based Nanosystem Mediates Drug Penetration and Irreversible Endoplasmic Reticulum Stresses in Tumor via Neighboring Effect
Xiuli Zheng, Dayi Pan, Guonian Zhu, et al.
Advanced Materials (2022) Vol. 34, Iss. 20
Closed Access | Times Cited: 42
Lipid Prodrug Nanoassemblies via Dynamic Covalent Boronates
Yuxun Ding, Xiaowen Hu, Yinzi Piao, et al.
ACS Nano (2023) Vol. 17, Iss. 7, pp. 6601-6614
Closed Access | Times Cited: 42
Functional Nucleic Acids-Engineered Bio-Barcode Nanoplatforms for Targeted Synergistic Therapy of Multidrug-Resistant Cancer
Shuangcheng Zhi, Xiaoyue Zhang, Jian Zhang, et al.
ACS Nano (2023) Vol. 17, Iss. 14, pp. 13533-13544
Closed Access | Times Cited: 42
Self-assembled nanoformulations of paclitaxel for enhanced cancer theranostics
Qing Pei, Bowen Jiang, Dengyuan Hao, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 8, pp. 3252-3276
Open Access | Times Cited: 28
Natural-product-based, carrier-free, noncovalent nanoparticles for tumor chemo-photodynamic combination therapy
Zhonglei Wang, Liyan Yang
Pharmacological Research (2024) Vol. 203, pp. 107150-107150
Open Access | Times Cited: 15
Endoperoxide‐enhanced self‐assembled ROS producer as intracellular prodrugs for tumor chemotherapy and chemodynamic therapy
Junjie Tang, Yadong Liu, Yifan Xue, et al.
Exploration (2024) Vol. 4, Iss. 4
Open Access | Times Cited: 13
Mitocytosis Mediated by an Enzyme‐Activable Mitochondrion‐Disturbing Polymer‐Drug Conjugate Enhances Active Penetration in Glioblastoma Therapy
Yufan Xiang, Bing Wang, Wanchun Yang, et al.
Advanced Materials (2024) Vol. 36, Iss. 18
Closed Access | Times Cited: 12
Taxanes prodrug-based nanomedicines for cancer therapy
Linlin Sun, Pan Zhao, Menghan Chen, et al.
Journal of Controlled Release (2022) Vol. 348, pp. 672-691
Closed Access | Times Cited: 32
A ROS-Responsive Simvastatin Nano-Prodrug and its Fibronectin-Targeted Co-Delivery System for Atherosclerosis Treatment
Runze Zhao, Xiaoyue Ning, Mengqi Wang, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 22, pp. 25080-25092
Closed Access | Times Cited: 31
Nanodrugs based on co-delivery strategies to combat cisplatin resistance
Qiubo Wang, Hui Li, Wu Taixia, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 14-42
Closed Access | Times Cited: 8
Single Molecular Nanomedicines Based on Macrocyclic Carrier-Drug Conjugates for Concentration-Independent Encapsulation and Precise Activation of Drugs
Shunyu Yao, An‐Kang Ying, Ze-Tao Jiang, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 20, pp. 14203-14212
Closed Access | Times Cited: 7
Recent Advances in Material Technology for Leukemia Treatments
Feng Li, Huaiji Wang, Tong Ye, et al.
Advanced Materials (2024) Vol. 36, Iss. 26
Closed Access | Times Cited: 5
Self-immolative polyprodrug-based tumor-specific cascade amplificated drug release nanosystem for orchestrated synergistic cancer therapy
Kewei Wang, Xuan Xiao, Ye Liu, et al.
Biomaterials (2022) Vol. 289, pp. 121803-121803
Closed Access | Times Cited: 19
The spatiotemporal journey of nanomedicines in solid tumors on their therapeutic efficacy
Mengmeng Qin, Heming Xia, Wenhao Xu, et al.
Advanced Drug Delivery Reviews (2023) Vol. 203, pp. 115137-115137
Closed Access | Times Cited: 13
Targeting self-enhanced ROS-responsive artesunatum prodrug nanoassembly potentiates gemcitabine activity by down-regulating CDA expression in cervical cancer
Shengtao Wang, Kunyi Yu, Zhiyu Yu, et al.
Chinese Chemical Letters (2023) Vol. 34, Iss. 7, pp. 108184-108184
Closed Access | Times Cited: 12
Engineering thio-/seleno-ether linkers into zwitterionic small molecule nano-prodrugs for traceable cancer theranostics
Sun Shi, Wenbi Feng, Zhitai Chen, et al.
Sensors and Actuators B Chemical (2023) Vol. 387, pp. 133771-133771
Closed Access | Times Cited: 12
Drug content on anticancer efficacy of self-assembling ketal-linked dextran-paclitaxel conjugates
Tiantian Guo, Haiping Zhong, Xingwei Li, et al.
Journal of Controlled Release (2023) Vol. 359, pp. 175-187
Closed Access | Times Cited: 11
A mitochondria-targeting heptamethine cyanine-chlorambucil formulated polymeric nanoparticle to potentiate native tumor chemotherapeutic efficacy
Jing Liu, Mingjie Zhang, Yongteng Zhang, et al.
Biomaterials Science (2024) Vol. 12, Iss. 10, pp. 2614-2625
Closed Access | Times Cited: 4
Phenylboronic Acid-Functionalized Copolypeptides: Facile Synthesis and Responsive Dual Anticancer Drug Release
Qiang Zhang, Yuanyuan Liu, Yucheng Fei, et al.
Biomacromolecules (2022) Vol. 23, Iss. 7, pp. 2989-2998
Closed Access | Times Cited: 18
Advances in stimulus-responsive nanomedicine for treatment and diagnosis of atherosclerosis
Jingying Mao, Chengxi Wu, Lixin Zheng, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 245, pp. 114298-114298
Closed Access | Times Cited: 3
ROS-responsive simvastatin nano-prodrug based on tertiary amine-oxide zwitterionic polymer for atherosclerotic therapy
Haiqin Yang, Mengcheng Guo, Qingran Guan, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Lipidic prodrug nanosponges deliver proteins for combination therapy of candida-biofilm infections
Yuanfeng Li, Yumeng Wang, Yinzi Piao, et al.
Nano Today (2025) Vol. 63, pp. 102759-102759
Closed Access
Page 1 - Next Page

Scroll to top